Subcutaneous fat necrosis of the newborn

We present the MRI findings in a case of subcutaneous fat necrosis of the newborn. To our knowledge, the MRI findings of this entity have not been reported. Subcutaneous fat necrosis of the newborn is an uncommon, benign process in full-term infants. Hypercalcemia may be a potentially life-threatening complication of this otherwise self-limiting process. Received: 30 December 1998 Accepted: 10 May 1999     

Primary endodermal sinus tumor of the liver detected by CT

We report a case of primary endodermal sinus tumor of the liver. Endodermal sinus tumors are rare neoplasms which usually arise in the testis or ovary. Extragonadal endodermal sinus tumors are uncommon and primary tumors of the liver are very rare. The tumor was detected using CT and the diagnosis was made by percutaneous biopsy.     

Renal lymphoma mimicking clear cell sarcoma in a pediatric patient

Lymphoma involving the kidneys typically presents as bilateral renal enlargement with multiple nodules [1–6]. Solitary masses, diffuse parenchymal infiltration, or engulfment of the entire kidney by diffuse disease may occur but are more rare. We report the case of a child with non-Hodgkin’s lymphoma presenting as a focal unilateral renal mass with bony metastases.

     

Pattern of poisoning in a developing agricultural country

Four hundred and seventy-two cases of poisoning were seen over a two-year period in Kandy, Ceylon. The overall mortality was 23·7%. The pattern of poisoning was different from that in western countries in that 49·8% of the cases were due to insecticide poisoning and only 10·7% were due to drugs, including barbiturates. Insecticides accounted for 73·2% and drugs for only 4·5% of the 112 fatal cases. Of the fatal cases 51·7% were between the ages of 20 and 40 years and only 6·2% were over 50 years. The wastage of economically useful lives indicates the need for a poison centre.     

Deformability and spectrin properties in three types of elongated red cells

Three types of unusual, elongated erythrocytes have been studied in our effort to understand factors that regulate the shape and deformability of red blood cells. Measurements of deformability, morphologic response to membrane-shape-altering drugs, spectrin phosphorylation, spectrin extractability, and casein kinase activity were measured in llama cells, irreversibly sickled cells, and nonhemolytic human elliptocytes. The results of these studies support the concept that the physical properties of spectrin are important in maintaining the shape and deformability of the erythrocyte. Furthermore, changes in spectrin extractability and phosphorylation appear to be associated with changes in the viscoelastic properties of the membrane. However, it seems that spectrin's regulatory role is permissive rather than direct and active.     

Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer

Background Cancer cells have an abnormal energetic metabolism. One of the earliest discovered hallmarks of cancer had its roots in bioenergetics, as many tumours were found in the 1920s to exhibit a high glycolytic phenotype. An animal with cancer shows significant and progressive energy loss from the host (i.e. noncancerous) tissues, which could occur by the establishment of a systemic energy-depriving cycle involving the interaction of tumour glycolysis and host gluconeogenesis. Tamoxifen (TAM) is a nonsteroidal antioestrogen that is widely used in adjuvant therapy for all stages of breast carcinoma. To improve the therapeutic efficacy of TAM and to expand its usage in the treatment of breast cancer, it is necessary to establish an energy-enhancing programme. In order to provide sufficient energy and to prevent cancer cachexia, TAM can be supplemented with energy-modulating vitamins (EMV). In this investigation the augmentation of the efficacy of TAM by the effects of EMV supplementation on carbohydrate-metabolizing enzymes, the mitochondrial Krebs cycle and respiratory enzymes was evaluated in the mammary gland of carcinoma-bearing rats.Methods Female albino Sprague-Dawley rats were selected for the investigation. The experimental set-up included one control and four experimental groups. Mammary carcinoma was induced with 7,12- dimethyl benz(a)anthracene (25 mg), and TAM was administered orally (10 mg/kg body weight per day) along with EMV which comprised riboflavin (45 mg/kg per day), niacin (100 mg/kg per day) and coenzyme Q₁₀ (40 mg/kg per day).Results Measurements were made on tumour tissue and surrounding normal tissue in all experimental groups. Tumour tissue showed significant (P<0.05) increases in the glycolytic enzymes hexokinase, phosphoglucoisomerase and aldolase, and significant decreases in the gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-biphosphatase. In contrast, the surrounding tissue showed significant decreases in glycolytic enzymes and significant increases in gluconeogenic enzymes. The activities of the mitochondrial Krebs cycle enzymes isocitrate dehydrogenase, -ketoglutarate dehydrogenase, succinate dehydrogenase and malate dehydrogenase, and respiratory chain enzymes NADH dehydrogenase and cytochrome c oxidase were significantly reduced in both tumour and surrounding tissue of the mammary carcinoma-bearing rats. These biochemical disturbances were effectively counteracted by supplementation with EMV, which restored the activities of all these enzyme to their respective control levels.Conclusion Combination therapy of TAM with EMV not only alters carbohydrate metabolism but can also prevent body weight loss by enhancing the host energy metabolism.